Valganciclovir hydrochloride (Valcyte®) is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases.

Administration

---

Orally, available in 450 mg pink tablets. Dosing is calculated to provide appropriate doses of ganciclovir; 900 mg of valganciclovir orally every 12 hours is equivalent to 5 mg per kilogram of body weight of intravenous ganciclovir, also every 12 hours.

More on [ Valganciclovir ]

Valganciclovir - Twitter Search

Ranbaxy Wins US court Ruling on Valganciclovir http://bit.ly/MHZfT
GenericPharma (Generic Pharma News) Sat, 17 Oct 2009 08:12:16 -0000
Ranbaxy Wins US court Ruling on Valganciclovir http://bit.ly/MHZfT
Anti-CMV Drug Cleared for Pediatric Transplant Patients: The FDA has approved Valcyte (valganciclovir hydrochlor.. http://bit.ly/10QxhC
renalandurology (Renal Urology News) Fri, 16 Oct 2009 18:38:06 -0000
Anti-CMV Drug Cleared for Pediatric Transplant Patients: The FDA has approved Valcyte (valganciclovir hydrochlor.. http://bit.ly/10QxhC
Via ipbiz- "Ranbaxy wins against Roche in DNJ on valganciclovir" - http://bit.ly/2nAQTG #patent
priorsmart (PriorSmart) Fri, 16 Oct 2009 12:48:30 -0000
Via ipbiz- "Ranbaxy wins against Roche in DNJ on valganciclovir" - http://bit.ly/2nAQTG #patent

Subscribe to Valganciclovir RSS feed